» Authors » Richard van Hillegersberg

Richard van Hillegersberg

Explore the profile of Richard van Hillegersberg including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 372
Citations 5224
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hagens E, Kingma B, van Berge Henegouwen M, Borggreve A, Ruurda J, van Hillegersberg R, et al.
Cancers (Basel) . 2025 Mar; 17(5). PMID: 40075734
To investigate the impact of paratracheal lymphadenectomy on survival in patients undergoing an esophagectomy for cancer. The secondary objective was to assess the effect on short-term outcomes. Between 2011-2017, patients...
2.
van der Linde M, Visser M, Eijkenaar F, Oude Voshaar M, van Hillegersberg R, van Sandick J, et al.
Eur J Surg Oncol . 2025 Feb; 51(6):109644. PMID: 40014956
Background: Clinical and pathological outcomes of oesophagogastric cancer surgery are used for benchmarking hospital performance. The extent to which case-mix adjustment is required for valid hospital comparisons is unknown. This...
3.
Kooij C, Boptsi E, Weusten B, de Vries D, Ruurda J, van Hillegersberg R
Surg Endosc . 2025 Feb; PMID: 39930122
Background: Boerhaave syndrome is a rare, life-threatening condition, characterized by spontaneous esophageal rupture. This study aims to share our 13-year experience in managing Boerhaave syndrome. Methods: A retrospective, observational study...
4.
van Laarhoven H, Verhoeven R, van Berge Henegouwen M, Haj Mohammad N, van Hillegersberg R, Slingerland M, et al.
EClinicalMedicine . 2025 Feb; 80:103067. PMID: 39911244
Background: Recent studies in patients with resectable adenocarcinoma of the esophagus or gastroesophageal junction (GEJ)-Neo-AEGIS and ESOPEC-have explored the comparison of neoadjuvant chemoradiotherapy (nCRT) with chemotherapy, with conflicting results. To...
5.
Wang J, de Jongh C, Wu Z, de Groot E, Markar S, Brenkman H, et al.
Eur J Surg Oncol . 2025 Feb; :109595. PMID: 39894712
Introduction: The pre-treatment waiting interval of gastric cancer patients receiving neoadjuvant chemotherapy (nCT) followed by gastrectomy includes pre-nCT (diagnosis to nCT) and preoperative (diagnosis to surgery) waiting intervals. This study...
6.
Kim T, Uyama I, Rha S, Bencivenga M, An J, Wyrwicz L, et al.
J Gastric Cancer . 2025 Jan; 25(1):133-152. PMID: 39822172
Conversion therapy is a treatment strategy that shifts from palliative systemic therapy to curative surgical treatment for primary and/or metastatic stage IV gastric cancer (GC). To address its clinical statements,...
7.
Reijneveld E, Kooij C, Dronkers J, Kingma B, Stel J, Sauer M, et al.
Eur J Surg Oncol . 2025 Jan; 51(3):109575. PMID: 39813770
Introduction: This study evaluates the course of physical fitness and nutritional status during curative therapy for esophageal cancer, after implementation of a prehabilitation program. Additionally, the impact of baseline physical...
8.
Visser M, Voeten D, Gisbertz S, Ruurda J, van Hillegersberg R, van Berge Henegouwen M
Ann Surg Oncol . 2025 Jan; 32(4):2706-2707. PMID: 39775690
No abstract available.
9.
Kroese T, Bronzwaer S, van Rossum P, van Laarhoven H, van Hillegersberg R
Curr Oncol Rep . 2025 Jan; 27(1):30-36. PMID: 39753813
Purpose Of The Review: This narrative review aims to provide an overview of recently completed randomized trials and expert consensus recommendations, and their implications for clinical practice and future trial...
10.
Visser M, Voeten D, Gisbertz S, Ruurda J, van Hillegersberg R, van Berge Henegouwen M
Ann Surg Oncol . 2024 Dec; 32(4):2687-2697. PMID: 39627639
Background: Salvage esophagectomy is more complex and associated with higher postoperative morbidity and mortality than standard resection. This study aimed to investigate short-term outcomes and the influence of hospital volume...